Priddy FH, Lewis DJM, Gelderblom HC, et al. Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial. Lancet HIV 2019; 6: e230–39—In the Results text, the neutralisation of CAP45.2.00.G3 has been corrected to ID50 titres in reciprocal dilution, not concentrations in μg/mL. This correction was made on April 3, 2019.
. 2019 Apr 4;6(12):e815. doi: 10.1016/S2352-3018(19)30107-9
Correction to Lancet HIV 2019; 6: e230–39
Collection date 2019 Dec.
© 2019 The Author(s). Published by Elsevier Ltd.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
PMCID: PMC7171809 PMID: 30954489
This corrects the article "Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial" on page e230.